We are live on ! Find out more
EGI

EAM Global Investors Portfolio holdings

AUM $47.1M
1-Year Est. Return 320.45%
This Fund
S&P 500
This Quarter Est. Return
+19.91%
1 Year Est. Return
+320.45%
3 Year Est. Return
+2,492.23%
5 Year Est. Return
+19,933.92%
10 Year Est. Return
–
AUM
$193M
AUM Growth
-$2.17M
Cap. Flow
-$16.6M
Cap. Flow %
-8.61%
Top 10 Hldgs %
24.88%
Holding
196
New
67
Increased
9
Reduced
31
Closed
61

Top Buys

Rank Stock Value
1
HRTX icon
Heron Therapeutics
HRTX
+$1.54M
2
PGTI
PGT, Inc.
PGTI
+$1.43M
3
PRO
PROS Holdings
PRO
+$1.42M
4
DENN
Denny's
DENN
+$1.4M
5
IMGN
Immunogen Inc
IMGN
+$1.4M

Top Sells

Rank Stock Value
1
GLIN icon
VanEck India Growth Leaders ETF
GLIN
+$11.8M
2
WGO icon
Winnebago Industries
WGO
+$2.46M
3
KOP icon
Koppers
KOP
+$1.71M
4
BBBY
Bed Bath & Beyond
BBBY
+$1.59M
5
LGIH icon
LGI Homes
LGIH
+$1.53M

Sector Composition

Rank Sector Weight
1 Healthcare 25.83%
2 Technology 18.96%
3 Industrials 12.2%
4 Consumer Discretionary 11.75%
5 Financials 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZGNX
76
DELISTED
Zogenix, Inc.
ZGNX
$1.18M 0.61%
29,350
– –
ENVA icon
77
Enova International
ENVA
$6.29B
$1.17M 0.61%
+53,228
New +$1.07M
PRDO icon
78
Perdoceo Education
PRDO
$2.12B
$1.17M 0.61%
88,974
– –
CIGI icon
79
Colliers International
CIGI
$5.19B
$1.17M 0.6%
+16,821
New +$1.06M
KMG
80
DELISTED
KMG Chemicals Inc
KMG
$1.16M 0.6%
19,390
– –
MGPI icon
81
MGP Ingredients
MGPI
$375M
$1.16M 0.6%
12,956
-4,589
-26% -$373K
CASH icon
82
Pathward Financial
CASH
$1.8B
$1.16M 0.6%
+31,719
New +$1.13M
CHGG icon
83
Chegg
CHGG
$102M
$1.15M 0.6%
55,818
– –
MYOK
84
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$1.14M 0.59%
23,255
– –
AQ
85
DELISTED
Aquantia Corp. Common Stock
AQ
$1.12M 0.58%
+71,335
New +$992K
MRTX
86
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.11M 0.58%
+36,335
New +$1.01M
PRFT
87
DELISTED
Perficient Inc
PRFT
$1.11M 0.58%
+48,511
New +$1.01M
LIVN icon
88
LivaNova
LIVN
$4.2B
$1.11M 0.57%
12,501
+290
+2% +$24.7K
GAIA icon
89
Gaia
GAIA
$48.4M
$1.1M 0.57%
+70,830
New +$931K
IOVA icon
90
Iovance Biotherapeutics
IOVA
$2.87B
$1.09M 0.57%
+64,545
New +$978K
TRUP icon
91
Trupanion
TRUP
$1.18B
$1.09M 0.56%
36,470
-6,282
-15% -$201K
RST
92
DELISTED
ROSETTA STONE INC
RST
$1.09M 0.56%
82,885
+1,610
+2% +$21K
CRSP icon
93
CRISPR Therapeutics
CRSP
$5.17B
$1.09M 0.56%
+23,820
New +$983K
COLL icon
94
Collegium Pharmaceutical
COLL
$956M
$1.08M 0.56%
+42,193
New +$1.01M
MCRI icon
95
Monarch Casino & Resort
MCRI
$2.23B
$1.08M 0.56%
25,477
-3,617
-12% -$159K
GALT icon
96
Galectin Therapeutics
GALT
$348M
$1.08M 0.56%
+227,063
New +$1.06M
GTHX
97
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.06M 0.55%
+28,713
New +$766K
MOD icon
98
Modine Manufacturing
MOD
$10.4B
$1.05M 0.54%
49,546
-12,250
-20% -$279K
HDP
99
DELISTED
Hortonworks, Inc.
HDP
$1.02M 0.53%
50,290
-10,351
-17% -$204K
NVAX icon
100
Novavax
NVAX
$1.31B
$1.02M 0.53%
+24,315
New +$977K
2 3
4
5 6

Similar funds

IPHI
Inflection Point Holdings II New York $47.3M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
PFA
Portland Financial Advisors Port Washington, New York $48.1M AUM 10.13% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CCG
Capital CS Group Irvine, California $48.6M AUM 11.64% 1-Year Est. Return

EAM Global Investors's Q1 2018 Portfolio in Review

As of Q1 2018, EAM Global Investors held 196 positions worth $193M, down 1.1% from $195M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

EAM Global Investors withdrew a net $16.6M in Q1 2018, closing 61 positions and reducing 31 holdings. Its most notable exit was Winnebago Industries, an estimated $2.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Global Investors opened a new position in Heron Therapeutics worth $1.87M.

  • EAM Global Investors's largest Q1 2018 buy was Heron Therapeutics: 67,801 shares worth $1.87M.
  • EAM Global Investors added most to DMC Global in Q1 2018, an estimated $297K increase.
  • EAM Global Investors's biggest Q1 2018 reduction was VanEck India Growth Leaders ETF, cutting an estimated $11.8M.
  • EAM Global Investors fully exited Winnebago Industries in Q1 2018, selling an estimated $2.46M.
  • EAM Global Investors's ten largest holdings make up 25% of its $193M portfolio in Q1 2018.
  • EAM Global Investors opened 67 new positions and closed 61 in Q1 2018.
  • EAM Global Investors's portfolio value fell 1.1% quarter-over-quarter to $193M.

Based on EAM Global Investors's 13F filing for Q1 2018, filed 4 Jun 2018.